A genomewide association study on susceptibility to HCV in HIV-1+ MSM
Research type
Research Study
Full title
A genomewide association study (GWAS) on susceptibility to sexual transmission of Hepatitis C virus (HCV) among HIV-1+ MSM
IRAS ID
226236
Contact name
Katrina Stegmann
Contact email
Sponsor organisation
Amsterdam Medical Centre
Duration of Study in the UK
1 years, 0 months, 0 days
Research summary
Rationale:
Despite high-risk behavior for hepatitis C (HCV) transmission and substantial prevalence in the population, some individuals remain uninfected, suggesting that host factors play a role in HCV susceptibility. To determine whether genetic factors play a role in HCV susceptibility we want to perform a genome wide association study (GWAS) on individuals at high risk for acquiring HCV, to identify single nucleotide polymorphisms (SNPs) in host genes.Objective:
To identify genetic host factors associated with HCV susceptibility among HIV-infected MSM.Study design:
This is a case-control study to be carried out at multiple HIV-treatment clinics in Amsterdam as well as HIV-treatment clinics in Berlin (Zentrum für Infektiologie, Berlin Prenzlauer Berg, Dr. P. Ingiliz) and New York (Mount Sinai Hospital and the Callen-Lorde Clinic, Dr. D. Fierer) and London (Chelsea and Westminster Hospital, Prof. M. Nelson). It is an observational study without invasive measurements. Participants will be requested to fill out a questionnaire allowing assessment of risk behaviour which facilitates HCV transmission. A buccal swab will be collected from each participant. DNA derived from the buccal swabs from cases and high-risk controls (i.e. a selection of all controls that are included) will be analysed using an Illumina ‘Global Screening Array’, enabling genotyping of 700.000 single nucleotide polymorphisms (SNPs).Study population:
HIV-infected men who have sex with men (MSM), 18+ yr old. Controls are HIV-infected MSM without (past) HCV infection. Cases are HIV-infected MSM with current or past HCV infection.Main study parameters/endpoints:
Identification of SNPs associated with HCV susceptibilityREC name
HSC REC A
REC reference
17/NI/0111
Date of REC Opinion
21 Jun 2017
REC opinion
Further Information Favourable Opinion